.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EB01_CromoglicicAcid.CromoglicicAcid .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EB01_CromoglicicAcid.CromoglicicAcid| name: | CromoglicicAcid | |
| ATC code: | A07EB01 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 200 | mg |
| volume of distribution: | 0.227 | L |
| clearance: | 316.8 | ml/min |
| other parameters in model implementation | ||
Cromoglicic acid, also known as cromolyn sodium, is a mast cell stabilizer used primarily in the treatment and prevention of allergic conditions such as asthma, allergic rhinitis, and allergic conjunctivitis. It reduces allergic symptoms by preventing the release of inflammatory mediators from sensitized mast cells. While once widely used, its use has declined with the advent of newer therapies, but it remains approved in certain formulations and regions.
Pharmacokinetic parameters as reported in healthy adult volunteers after oral administration.